Industry Focus Areas, Medical, Regulations
October 20, 2022
Via: The Wall Street JournalDrugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing influence in Washington, D.C. Under the Inflation Reduction Act, Congress gave Medicare, the country’s biggest buyer of prescription drugs, the […]
July 9, 2024
June 25, 2024